Simplify Asset Management Inc. United Therapeutics Corp Transaction History

Simplify Asset Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$205.95 - $280.43 $1.36 Million - $1.85 Million	-6,606 Reduced 83.47%	1,308 $363,000
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $503,167 - $604,320	2,475 Added 45.5%	7,914 $1.66 Million
Q2 2022 Aug 11, 2022	BUY	$174.81 - $241.14 $190,368 - $262,601	1,089 Added 25.03%	5,439 $1.28 Million
Q1 2022 May 13, 2022	BUY	$166.16 - $213.96 $361,896 - $466,004	2,178 Added 100.28%	4,350 $780,000
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $400,343 - $469,325	2,172 New	2,172 $469,000

681

42.2M

194K

298K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Simplify Asset Management Inc. with notifications on news.